An observational cohort study of SARS-CoV-2 live virus neutralization after four COVID-19 vaccine doses in people with HIV receiving suppressive ART
Latest Information Update: 24 Feb 2023
Price :
$35 *
At a glance
- Drugs Elasomeran (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
- 24 Feb 2023 New trial record
- 22 Feb 2023 Results investigating the relationship between sociodemographic, health and vaccine-related variables and SARS-CoV-2 neutralization presented at the 30th Conference on Retroviruses and Opportunistic Infections 2023
- 14 Feb 2023 Results published in the AIDS